Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recruiting × Epinephrine × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Completed 3 Terminated 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Postoperative Hemorrhage 1

Interventions

pembrolizumab 205 Carboplatin 189 Specimen Handling 171 Cisplatin 169 Magnetic Resonance Spectroscopy 149 Radiotherapy 128 Bevacizumab 121 Gemcitabine 111 Cyclophosphamide 109 Drug Therapy 104 Capecitabine 100 Paclitaxel 97 venetoclax 96 Nivolumab 95 Biopsy 86 Oxaliplatin 85 durvalumab 74 tislelizumab 72 Rituximab 71 toripalimab 61 Radiosurgery 61 Etoposide 61 atezolizumab 60 Fluorouracil 60 Docetaxel 60 Pemetrexed 58 Dexamethasone 56 Azacitidine 54 lenvatinib 52 sintilimab 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06057675 2025-08-19

Tranexamic Acid in Nasal Mohs Reconstruction

Vanderbilt University Medical Center

Phase 2 Recruiting

Postoperative Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡